Search Orphan Drug Designations and Approvals
-
Generic Name: | Modafinil | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Provigil | ||||||||||||||||
Date Designated: | 03/15/1993 | ||||||||||||||||
Orphan Designation: | Treatment of excessive daytime sleepiness in narcolepsy. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Cephalon, Inc. 145 Brandywine Parkway West Chester, Pennsylvania 19380 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Modafinil |
---|---|---|
Trade Name: | Provigil | |
Marketing Approval Date: | 12/24/1998 | |
Approved Labeled Indication: | Improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy. | |
Exclusivity End Date: | 12/24/2005 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-